To examine the effects of Gpr132 deletion in the tumor environment on cancer growth in vivo, we injected EO771 mouse breast cancer cells into the mammary fat pad of Gpr132-KO mice and WT littermate controls. The gene discussed is GPR132; the disease is breast carcinoma.